Your session is about to expire
← Back to Search
Aerobic Exercise for Cognitive Impairment
N/A
Recruiting
Led By Curtis L Johnson, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
age 60-90 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks
Awards & highlights
Study Summary
This trial will look at whether older adults with low memory abilities can improve their brain health through aerobic exercise.
Who is the study for?
This trial is for adults aged 60-90 with mild memory issues but generally good mental function (MMSE score >24). They should not have high blood pressure, claustrophobia, metal implants, pacemakers, serious illnesses like heart disease or diabetes, recent concussions or be current smokers. Those on certain CNS-affecting meds or with major psychiatric disorders are also excluded.Check my eligibility
What is being tested?
The study tests if aerobic exercise can improve brain structure and memory in older adults by using a special MRI technique called magnetic resonance elastography. Participants will either do aerobic exercises or stretching to see which affects the brain and memory more positively.See study design
What are the potential side effects?
While there aren't direct side effects from the interventions being studied (aerobic exercise and stretching), participants may experience general risks associated with physical activity such as muscle strain or injury.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 60 and 90 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in brain mechanical properties
Secondary outcome measures
Change in cardiorespiratory fitness
Change in relational memory performance
Other outcome measures
Change in brain function
Change in brain morphometry
Change in brain white matter integrity
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Aerobic exerciseExperimental Treatment1 Intervention
Exercise training
Group II: StretchingActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic exercise
2000
Completed Phase 2
~1130
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,004,954 Total Patients Enrolled
University of Illinois at Urbana-ChampaignOTHER
188 Previous Clinical Trials
37,175 Total Patients Enrolled
University of DelawareLead Sponsor
154 Previous Clinical Trials
25,051 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a condition like Parkinson's, epilepsy, or MS affecting my thinking.I am not on medications that affect brain function.I have no major illnesses like heart disease, kidney failure, or diabetes.I am between 60 and 90 years old.You have a serious mental illness like schizophrenia, bipolar disorder, or major depression within the past two years.You have smoked tobacco or used marijuana in the last 3 months.My blood pressure is high, over 130/80 mmHg.I have had a concussion in the past 2 years and more than 3 in my lifetime.
Research Study Groups:
This trial has the following groups:- Group 1: Stretching
- Group 2: Aerobic exercise
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies within this research project for participants?
"Clinicaltrials.gov shows that this trial is currently recruiting participants, having been first posted on March 1st 2019 and last edited April 26th 2021."
Answered by AI
What qualifications must potential participants meet to enroll in this trial?
"Sixty individuals exhibiting signs of cognitive deterioration that are between 60-90 years old can join this clinical trial. Entrants must also have achieved a minimum score on the MMSE evaluation and demonstrate pre-screening results consistent with amnestic mild cognitive impairment."
Answered by AI
Are participants in this research restricted to those over 20 years of age?
"Eligible participants for this medical experiment must be between 60 and 90 years old."
Answered by AI
What is the upper limit of participants involved in this investigation?
"Affirmative. Clinicialtrials.gov hosts information that indicates this medical research is currently seeking participants, as it was last updated on April 26th 2021 and originally posted on March 1st 2019. Sixty individuals must be recruited from one location for the study to reach completion."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger